Latest Transformation News

Skin Elements Limited reports successful completion of key product evaluations and secures $2.5 million placement to fuel growth and commercialisation in 2026.

FBR Limited unveiled its new DST-enabled Mantis welding robot targeting heavy fabrication sectors while completing key milestones on its Hadrian bricklaying technology and securing a $22 million financing package.

Greenvale Energy’s maiden drilling at the Oasis Uranium Project delivers multiple high-grade uranium intercepts, while the company expands its tenure in the Northern Territory’s prolific Pine Creek region.

Metal Bank Limited is advancing its Western Australia gold strategy with significant resource development at Livingstone and a binding agreement to acquire Hastings Technology Metals’ WA gold assets, while also progressing critical minerals projects in Queensland and Saudi Arabia.

Argent BioPharma has secured a transformative acquisition of AusCann’s core assets, bolstering its drug delivery technology and manufacturing capabilities ahead of a planned U.S. listing. The company also reported key clinical milestones and refinancing moves in its September 2025 quarterly update.

PARKD Limited has raised $1 million to fund its East Coast expansion, secured a new prefabrication facility in NSW, and landed its first pilot project with McNab Group, marking a pivotal step in its national rollout.

Tinybeans Group Limited reports steady subscription revenue and improved cash flow in Q1 FY26, while launching a new iOS Photo Store to diversify income streams and enhance user monetisation.

Tryptamine Therapeutics has initiated the world’s first clinical trial of its IV-infused psilocin drug, TRP-8803, targeting Binge Eating Disorder, alongside a pioneering EEG biomarker collaboration and new funding.

Pointerra Limited reported a stronger Q1 FY26 with nearly A$2 million in customer receipts and advancing AI-powered digital twin solutions across key sectors, setting the stage for improved cash flow and expanded market presence.

Nexion Group has completed the sale of its networks business for $4.1 million, marking a strategic pivot towards data centre operations and its AI-driven FuseAI software platform. The company is restructuring and preparing to resume ASX trading amid evolving revenue streams.

Tartana Minerals reports a significant new gold resource estimate at Cardross alongside robust copper sulphate sales and strategic board changes, positioning itself as a rising copper-gold producer in Far North Queensland.

InhaleRx has secured FDA alignment and ethics approvals to progress clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, with patient dosing set to begin soon.